
Skin Cancer
Latest News

Latest Videos

CME Content
More News

Whitney Hovenic, MD's new SPOOGE sunscreen hopes to engage Gen Z in sun protection, merging skincare with fun and effective sun care strategies.

Discover how the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai leads in innovative skin cancer care and research, celebrating a decade of excellence.

Whitney Hovenic, MD, highlights alarming trends in Gen Z's sun protection habits and introduces SPOOGE, a new sunscreen brand promoting skin health.

At Elevate-Derm Summer, Buchi Neita, MCMSc, PA-C, discussed enhancing dermatologic care for patients with skin of color by recognizing characteristics in common conditions and offered strategies to build rapport with patients.

Anisha Patel, MD, highlights dermatology's vital role in cancer care, discussing skin indicators and innovative immunotherapy at her Elevate-Derm Summer sessions.

Discover how gene expression profiling transforms melanoma and SCC management, enhancing personalized treatment strategies and improving patient outcomes in skin cancer care.

Castle Biosciences’ DecisionDx-Melanoma test plays a role in melanoma management with precise risk stratification, enhancing patient outcomes and reducing unnecessary surgeries.

Replimune faces FDA challenges for RP1's approval in advanced melanoma, highlighting complexities in cancer drug development and regulatory scrutiny.

This review of the latest dermatologic studies includes insights into ocular safety during laser procedures, radiation dermatitis prevention and management, and more.

At a recent Dermatology Times Case-Based Roundtable event, Gaurav Singh, MD, MPH, FAAD, FACMS, utilized 3 patient cases to explore the role of GEP testing in melanoma and SCC.

This review of the latest dermatologic studies includes insights into immunomodulatory effects of photodynamic therapy for skin cancer, in vivo and ex vivo sonographic evaluation of tumor margins, and more.

Artificial Intelligence (AI) enhances early detection of high-risk cutaneous squamous cell carcinoma (cSCC) by integrating advanced histopathological assessments for improved patient outcomes.

E-learning enhances skin cancer detection by training professionals in optical coherence tomography (OCT) for accurate differentiation between basal cell carcinoma (BCC) and non-BCC lesions.

At a recent Dermatology Times Case-Based Roundtable event, Andrew Baker, PA-C, MBA, explored the management of skin cancers with GEP testing through 4 complex cases.

Discover essential sun protection strategies from Dr. Susan Taylor, focusing on the impacts of UV, visible light, and personalized sunscreen choices.

New research highlights the importance of tinted sunscreens with iron oxides for effective protection against visible light-induced skin pigmentation, especially for darker skin tones.

Explore the latest insights, strategies, and treatments for patients with skin cancer as Dermatology Times looks back on Melanoma and Skin Cancer Awareness Month.

Peter Graylin shares his transformative skin cancer journey, emphasizing the importance of early detection, sun safety, and accessible dermatology programs.

AI Medical Technology launches Dermalyser, an AI tool for melanoma diagnosis, enhancing detection accuracy and skin cancer care in Europe.

As melanoma rates rise, Victor Gall, MD, emphasizes proactive care, early detection, and innovative treatments to improve patient outcomes and survival rates.

A melanoma survivor shares her journey, emphasizing the importance of early detection and regular skin exams for skin cancer awareness.

New research explores how microgravity and cosmic radiation influence cancer cell behavior, immune responses, and potential advancements in oncology treatments.

A melanoma survivor shares her journey, emphasizing the importance of sun safety and regular skin exams to prevent skin cancer.

The Skin Cancer Foundation's gala raises over $800,000, featuring Christie Brinkley and highlighting vital skin cancer awareness initiatives and personal stories.

Integrating molecular testing into melanoma and SCC management enhances risk assessment and personalizes treatment, revolutionizing patient care in dermatology.



























